Manage episode 304356960 series 2794871
Instead of trying therapies and hoping for the best, the RECOVERY trial investigators designed randomized trials to test which therapeutics were truly effective for COVID-19. Dr Harrington interviews lead investigator Martin Landray, MB ChB, PhD.
To read a transcript or to comment:
The Bob Harrington Show is intended for healthcare professionals.
RECOVERY Trial Website and Some Publications
Randomized Evaluation of COVID-19 Therapy
Dexamethasone in Hospitalized Patients with Covid-19
Lopinavir–ritonavir in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial
Remdesivir for the Treatment of Covid-19 — Final Report https://www.nejm.org/doi/full/10.1056/nejmoa2007764
Dexamethasone in Hospitalized Patients with Covid-19 https://www.nejm.org/doi/full/10.1056/nejmoa2021436
Effect of Hydroxychloroquine in Hospitalized Patients with Covid-19
Clinical Trials and Informed Consent
The good Clinical Trials Collaborative
Why do we need some large, simple randomized trials?
Assessment of Length and Readability of Informed Consent Documents for COVID-19 Vaccine Trials
You may also like:
Medscape Editor-in-Chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine
Hear John Mandrola, MD's summary and perspective on the top cardiology news each week, on This Week in Cardiology
Questions or feedback? Please contact: